Elke dag verbeteren de 52.000 medewerkers van Boehringer Ingelheim het leven van mensen en dieren. Download hier de laatste persberichten van Boehringer Ingelheim
Discover where Boehringer Ingelheim's scientific research efforts and investment is currently focused on including CNS diseases, Retinal Health & COVID-19.
Learn more on our goal to improve the lives of patients worldwide with medical breakthroughs and innovation, including over 100 products in the pipeline.
One of the most important elements at Boehringer Ingelheim is our responsibility to protecting the connection between human, animal and environmental health.
Boehringer Ingelheim developed the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, now used worldwide.
At Boehringer Ingelheim we are dedicated to working on improving treatments for cancer patients everywhere with a focus on lung and gastrointestinal cancers.
Fostering science via partnerships & collaborating is crucial for developing effective treatments which can transform patients lives. Find out more here.
Our animal health products are powered by innovation, with an aim to provide advanced preventive smart solutions. See our animal health products below.